July 12, 2017 / 11:59 AM / in 12 days

BRIEF-Immunovaccine announces achievement in personalized cancer medicines

1 Min Read

July 12 (Reuters) - Immunovaccine Inc

* Immunovaccine achieves breakthrough in support of developing personalized cancer immunotherapies

* Immunovaccine Inc - ‍filed a patent application covering the novel DepoVax-based rapid formulation process​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below